AbbVie Gives Up On One Of Alector’s Alzheimer’s Candidates But Plenty More In Pipeline

Partners Still Working On Another Drug

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.